相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Evaluation of Drinking Risk Levels as Outcomes in Alcohol Pharmacotherapy Trials A Secondary Analysis of 3 Randomized Clinical Trials
Daniel E. Falk et al.
JAMA PSYCHIATRY (2019)
The Use of Functional Magnetic Resonance Imaging to Test Pharmacotherapies for Alcohol Use Disorder: A Systematic Review
Erica N. Grodin et al.
ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH (2019)
State-of-the-art behavioral and pharmacological treatments for alcohol use disorder
Lara A. Ray et al.
AMERICAN JOURNAL OF DRUG AND ALCOHOL ABUSE (2019)
Phase 2 Trial of Ibudilast in Progressive Multiple Sclerosis
R. J. Fox et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
The Neuroimmune Basis of Excessive Alcohol Consumption
Jody Mayfield et al.
NEUROPSYCHOPHARMACOLOGY (2017)
Peripheral immune system suppression in early abstinent alcohol-dependent individuals: Links to stress and cue-related craving
Helen C. Fox et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2017)
PDE4 Inhibition Restores the Balance Between Excitation and Inhibition in VTA Dopamine Neurons Disrupted by Repeated In Vivo Cocaine Exposure
Xiaojie Liu et al.
NEUROPSYCHOPHARMACOLOGY (2017)
Development of the Neuroimmune Modulator Ibudilast for the Treatment of Alcoholism: A Randomized, Placebo-Controlled, Human Laboratory Trial
Lara A. Ray et al.
NEUROPSYCHOPHARMACOLOGY (2017)
Predictors of Naltrexone Response in a Randomized Trial: Reward-Related Brain Activation, OPRM1 Genotype, and Smoking Status
Joseph P. Schacht et al.
NEUROPSYCHOPHARMACOLOGY (2017)
Can reduced drinking be a viable goal for alcohol dependent patients?
Karl Mann et al.
WORLD PSYCHIATRY (2017)
Differences between treatment-seeking and non-treatment-seeking participants in medication studies for alcoholism: do they matter?
Lara A. Ray et al.
AMERICAN JOURNAL OF DRUG AND ALCOHOL ABUSE (2017)
Change in non-abstinent WHO drinking risk levels and alcohol dependence: a 3 year follow-up study in the US general population
Deborah S. Hasin et al.
LANCET PSYCHIATRY (2017)
Neural substrates of cue reactivity: association with treatment outcomes and relapse
Kelly E. Courtney et al.
ADDICTION BIOLOGY (2016)
Discovery, Development, and Adoption of Medications to Treat Alcohol Use Disorder: Goals for the Phases of Medications Development
Raye Z. Litten et al.
ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH (2016)
The Reasons for Heavy Drinking Questionnaire: Factor Structure and Validity in Alcohol-Dependent Adults Involved in Clinical Trials
Zachary W. Adams et al.
JOURNAL OF STUDIES ON ALCOHOL AND DRUGS (2016)
Ibudilast reduces alcohol drinking in multiple animal models of alcohol dependence
Richard L. Bell et al.
ADDICTION BIOLOGY (2015)
Inflamed moods: A review of the interactions between inflammation and mood disorders
Joshua D. Rosenblat et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2014)
Functional neuroimaging studies of alcohol cue reactivity: a quantitative meta-analysis and systematic review
Joseph P. Schacht et al.
ADDICTION BIOLOGY (2013)
Medications development to treat alcohol dependence: a vision for the next decade
Raye Z. Litten et al.
ADDICTION BIOLOGY (2012)
Role of intestinal permeability and inflammation in the biological and behavioral control of alcohol-dependent subjects
Sophie Leclercq et al.
BRAIN BEHAVIOR AND IMMUNITY (2012)
Glial Cell Line-Derived Neurotrophic Factor Reverses Alcohol-Induced Allostasis of the Mesolimbic Dopaminergic System: Implications for Alcohol Reward and Seeking
Segev Barak et al.
JOURNAL OF NEUROSCIENCE (2011)
Stability of fMRI striatal response to alcohol cues: A hierarchical linear modeling approach
Joseph P. Schacht et al.
NEUROIMAGE (2011)
Neurocircuitry of Addiction
George F. Koob et al.
NEUROPSYCHOPHARMACOLOGY (2010)
Allosteric inhibition of macrophage migration inhibitory factor revealed by ibudilast
Yoonsang Cho et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
BDNF and GDNF serum levels in alcohol-dependent patients during withdrawal
Annemarie Heberlein et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2010)
The glial activation inhibitor AV411 reduces morphine-induced nucleus accumbens dopamine release
Sondra T. Bland et al.
BRAIN BEHAVIOR AND IMMUNITY (2009)
Elevated cyclic AMP and PDE4 inhibition induce chemokine expression in human monocyte-derived macrophages
Angie L. Hertz et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Enhanced PDE4B expression augments LPS-inducible TNF expression in ethanol-primed monocytes: relevance to alcoholic liver disease
Leila Gobejishvili et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2008)
Increased MCP-1 and microglia in various regions of the human alcoholic brain
Jun He et al.
EXPERIMENTAL NEUROLOGY (2008)
The inhibitory profile of Ibudilast against the human phosphodiesterase enzyme family
Lucien C. D. Gibson et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2006)
Neuroprotective role of phosphodiesterase inhibitor ibudilast on neuronal cell death induced by activated microglia
T Mizuno et al.
NEUROPHARMACOLOGY (2004)
Improved optimization for the robust and accurate linear registration and motion correction of brain images
M Jenkinson et al.
NEUROIMAGE (2002)
The GDNF family: Signalling, biological functions and therapeutic value
MS Airaksinen et al.
NATURE REVIEWS NEUROSCIENCE (2002)
Macrophage migration inhibitory factor (MIF) sustains macrophage proinflammatory function by inhibiting p53: Regulatory role in the innate immune response
RA Mitchell et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Phosphodiesterase type 4 isozymes expression in human brain examined by in situ hybridization histochemistry and [3H]rolipram binding autoradiography -: Comparison with monkey and rat brain
S Pérez-Torres et al.
JOURNAL OF CHEMICAL NEUROANATOMY (2000)
分享论文
